Sector portfolio · VC firm · United States

Flagship Pioneering's Biotech portfolio

Flagship Pioneering has backed 25 Biotech startups in rounds we track, $3.1B between them, shown by the stage each has reached. The best-funded is Denali Therapeutics.

25startups backed
4stages
$3.1Braised between them
Stage not reportedbiggest stage

Flagship Pioneering's whole portfolioFlagship Pioneering's profile

Segment by segment

Stage not reported

8 startups · $688M raised

  1. Rubius TherapeuticsRubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.United States$300M
  2. Kaleido BioSciencesKaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.United States$161M
  3. CygnalCygnal is a polling & survey research firm serving center-right consultant, caucus, committee, political & advocacy organizations.United States$65M
  4. Metaphore BiotechnologiesMetaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.United States$50M
  5. Omega TherapeuticsOmega Therapeutics offers a proprietary epigenomic programming platform.United States$40M
  6. Tarveda TherapeuticsTarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.United States$36M
  7. AxcellaAxcella is a biotechnology company that treats diseases using endogenous metabolic modulators.United States$34M
  8. Apriori BioApriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.United States$1.1M

Series A

6 startups · $335M raised

  1. Codiak BiosciencesCodiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.United States$100M
  2. Vesalius TherapeuticsVesalius Therapeutics is a biopharmaceutical company dedicated to redefining the understanding and treatment of diseases that accoUnited States$75M
  3. ProFound TherapeuticsProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics.United States$75M
  4. EtiomeEtiome is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.United States$50M
  5. TorqueTorque is an open-source framework provider that specializes in self-configuring cloud systems for development operations (DevOps).United States$25M
  6. BBoragenUnited States$10M

Series C and later

6 startups · $683M raised

  1. KSQ TherapeuticsKSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.United States$156M
  2. Senda BiosciencesSenda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.United States$123M
  3. CellarityCellarity is a biotechnology therapeutics company based in Somerville, Massachusetts, founded in 2017 by Flagship Pioneering.United States$121M
  4. VisterraVisterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.United States$120M
  5. Ring TherapeuticsRing Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 by Flagship Pioneering.United States$87M
  6. CCodiakUnited States$77M

Series B

5 startups · $1.4B raised

  1. Denali TherapeuticsDenali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.United States$547M
  2. LarondeLaronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.United States$440M
  3. Repertoire Immune MedicinesRepertoire Immune Medicines is a clinical stage biotechnology company.-$189M
  4. AlltrnaAlltrna is a biotechnology company based in Cambridge, Massachusetts, founded in 2018.United States$109M
  5. Evelo BiosciencesEvelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.United States$76M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Flagship Pioneering as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Flagship Pioneering?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.